Flisiński Mariusz, Manitius Jacek
Katedra i Klinika Nefrologii, Nadciśnienia Tetniczego i Chorób Wewnetrznych Akademii Medycznej, Bydgoszczy.
Pol Merkur Lekarski. 2005 Aug;19(110):206-10.
Atherosclerotic renovascular disease (ARVD) is defined as a reduction in glomerular filtration rate in patient with significant renovascular bilateral occlusive disease or unilateral in a solitary kidney. ARVD is a frequent and potentially avoidable cause of end stage renal failure and the need for replacement therapy among person above 50 years old. Use of balloon angioplasty with stenting or surgical repair has been shown to improve renal potency, but there is no clear evidence that it prevents further progressive decline of renal function or blood pressure, compared to medical therapy alone. It is now recognized that severity of histopathologic damage is an important determinant and predictor of renal functional outcome. Proteinuria increases with declining renal failure and reflects the severity of parenchymal damage. Proteinuria and high renal resistance index are associated with glomerular damage and altered intrarenal perfusion. They aren't linked to renal artery stenosis (RAS) grade. Recent study indicate that abrupt decline in renal function reflects reversibility after revascularization. This should probably be undertaken in RAS patients with rapidly deteriorating renal function, refractory hypertension and in whom plasma creatinine concentration has increased by >20% during one month long administration of angiotensin-converting enzyme inhibitor. Renal biopsy may be useful to evaluate patient who will have advantage from revascularization.
动脉粥样硬化性肾血管疾病(ARVD)被定义为患有严重双侧肾血管闭塞性疾病或单肾单侧病变患者的肾小球滤过率降低。ARVD是50岁以上人群终末期肾衰竭及需要替代治疗的常见且可能可避免的原因。已表明使用球囊血管成形术加支架置入或手术修复可改善肾功能,但与单纯药物治疗相比,尚无明确证据表明其能防止肾功能或血压进一步逐渐下降。现在人们认识到组织病理学损伤的严重程度是肾功能结果的重要决定因素和预测指标。蛋白尿随肾衰竭程度加重而增加,反映了实质损伤的严重程度。蛋白尿和高肾阻力指数与肾小球损伤及肾内灌注改变有关。它们与肾动脉狭窄(RAS)分级无关。最近的研究表明,肾功能突然下降反映了血管重建后的可逆性。这可能适用于肾功能迅速恶化、难治性高血压且在服用血管紧张素转换酶抑制剂一个月期间血浆肌酐浓度升高>20%的RAS患者。肾活检可能有助于评估将从血管重建中获益的患者。